We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/OB/GYN & Women's Health

OB/GYN & Women's Health

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Evaluating Metformin Addition to Paclitaxel/Carboplatin in Advanced and Recurrent Endometrial Cancer: Insights from an NRG Oncology/GOG Phase II/III Trial
OB/GYN & Women's Healthchemotherapyclinical trial

Evaluating Metformin Addition to Paclitaxel/Carboplatin in Advanced and Recurrent Endometrial Cancer: Insights from an NRG Oncology/GOG Phase II/III Trial

By MedXY|Oct 8, 2025

This phase II/III study assessed whether adding metformin to standard paclitaxel and carboplatin improved outcomes in advanced and recurrent endometrial cancer. The trial was stopped early due to lack of survival benefit and potential harm,

Enhanced Therapeutic Outcomes in Overweight/Obese Women with PCOS: Combining Metformin and Semaglutide
Clinical Updatesmetforminobesity

Enhanced Therapeutic Outcomes in Overweight/Obese Women with PCOS: Combining Metformin and Semaglutide

By MedXY|Oct 7, 2025

Combination therapy with metformin and semaglutide improves weight loss, metabolic parameters, menstrual function, and natural pregnancy rates in overweight/obese women with PCOS compared to metformin alone.

Metabolic Health in Pregnancy: Unveiling the Differential Impact of Prenatal Behavioral Interventions on Obesity Phenotypes
Clinical Updatesgestational weight gain

Metabolic Health in Pregnancy: Unveiling the Differential Impact of Prenatal Behavioral Interventions on Obesity Phenotypes

By MedXY|Oct 7, 2025

This analysis reveals that metabolic health phenotypes, rather than gestational weight gain alone, significantly influence maternal and infant outcomes in prenatal behavioral interventions among obese pregnant women.

Transcutaneous Auricular Vagus Nerve Stimulation: A Novel Approach to Managing Postpartum Uterine Contraction Pain after Cesarean Delivery
AnesthesiologyCesarean Deliveryclinical trial

Transcutaneous Auricular Vagus Nerve Stimulation: A Novel Approach to Managing Postpartum Uterine Contraction Pain after Cesarean Delivery

By MedXY|Oct 7, 2025

A randomized clinical trial shows that transcutaneous auricular vagus nerve stimulation significantly reduces postpartum uterine contraction pain, incisional pain, anxiety, and depression, enhancing recovery and sleep quality in cesarean de

Enhancing Cervical Cancer Screening in Underserved Populations: Insights from the PRESTIS Randomized Clinical Trial
Clinical UpdatesCervical Cancer Screeningself-collection

Enhancing Cervical Cancer Screening in Underserved Populations: Insights from the PRESTIS Randomized Clinical Trial

By MedXY|Oct 7, 2025

The PRESTIS trial demonstrates that mailed self-collection kits significantly increase cervical cancer screening participation in a safety-net health system, with additional benefits from patient navigation support.

Open Anterior Mesh Repair Versus Modified Technique for Groin Hernia in Women: Insights from a Ugandan Randomized Trial
General Surgerygroin herniarandomized clinical trial

Open Anterior Mesh Repair Versus Modified Technique for Groin Hernia in Women: Insights from a Ugandan Randomized Trial

By MedXY|Oct 7, 2025

A randomized clinical trial in Uganda compared standard open anterior mesh repair with a modified technique addressing femoral hernias, demonstrating both methods as safe and effective options for women’s groin hernia repair in low-re

In Utero Embolization for Fetal Vein of Galen Malformation: Early Clinical Insights and Outcomes
newsNeurodevelopmental Outcomespreterm delivery

In Utero Embolization for Fetal Vein of Galen Malformation: Early Clinical Insights and Outcomes

By MedXY|Oct 7, 2025

This article reviews early clinical results from a US single-center study on in utero embolization for fetal Vein of Galen malformation, highlighting potential survival benefits alongside risks of preterm delivery.

Innovations in Prenatal Care: In Utero Embolization for Vein of Galen Malformation
Clinical UpdatesneurodevelopmentVein of Galen malformation

Innovations in Prenatal Care: In Utero Embolization for Vein of Galen Malformation

By MedXY|Oct 7, 2025

In utero embolization for fetal Vein of Galen malformation shows early promise in reducing mortality and neurodevelopmental delays, despite increased risk of preterm delivery.

Beyond Cervical Cancer: The Rising Threat of HPV-Linked Oropharyngeal Cancer in Men
Medical Newscervical cancerHPV

Beyond Cervical Cancer: The Rising Threat of HPV-Linked Oropharyngeal Cancer in Men

By MedXY|Oct 7, 2025

HPV-related oropharyngeal cancer incidence has surpassed cervical cancer, with men facing a 5-10 fold higher risk. Understanding this shift, symptoms, risks, and the critical role of HPV vaccination can transform prevention and early detect

Breastfeeding After Hormone Receptor-Positive Breast Cancer: Insights From the POSITIVE Trial
Clinical UpdatesBreastfeedingPregnancy

Breastfeeding After Hormone Receptor-Positive Breast Cancer: Insights From the POSITIVE Trial

By MedXY|Oct 7, 2025

The POSITIVE trial reveals that two thirds of women with early hormone receptor-positive breast cancer successfully breastfed post-treatment, without a significant increase in cancer recurrence risk, offering reassurance to women considerin

ADAGIO Trial Illuminates Adavosertib’s Potential in Recurrent Uterine Serous Carcinoma Amidst Safety Challenges
OB/GYN & Women's Healthclinical trial

ADAGIO Trial Illuminates Adavosertib’s Potential in Recurrent Uterine Serous Carcinoma Amidst Safety Challenges

By MedXY|Oct 7, 2025

The ADAGIO phase IIb study assessed adavosertib in recurrent uterine serous carcinoma post-platinum therapy, revealing modest efficacy and significant toxicity, with biomarker trends suggesting CCNE1/cyclin E1 as potential response predicto

EPIK-O Trial Explores Alpelisib plus Olaparib Versus Chemotherapy in Platinum-Resistant High-Grade Serous Ovarian Cancer Without BRCA Mutation
Clinical Updateshigh-grade serous ovarian cancerolaparib

EPIK-O Trial Explores Alpelisib plus Olaparib Versus Chemotherapy in Platinum-Resistant High-Grade Serous Ovarian Cancer Without BRCA Mutation

By MedXY|Oct 6, 2025

The phase III EPIK-O trial showed no progression-free survival benefit of alpelisib plus olaparib over chemotherapy in BRCA wild-type platinum-resistant or refractory high-grade serous ovarian cancer, highlighting treatment challenges and b

Top Ten Research Priorities in Menopause: A Comprehensive Evidence-Based Review
Clinical Updatesbreast cancercognitive decline

Top Ten Research Priorities in Menopause: A Comprehensive Evidence-Based Review

By MedXY|Oct 6, 2025

This review synthesizes the Menopause Priority Setting Partnership findings, highlighting the top ten evidence-based research priorities addressing non-hormonal treatments, lifestyle interventions, cognitive and sleep changes, hormone thera

Targeted Reduction of Sitting Time Versus Increased Sit-to-Stand Transitions: Effects on Blood Pressure and Glucose Regulation in Postmenopausal Women
Cardiologyblood pressurepostmenopausal women

Targeted Reduction of Sitting Time Versus Increased Sit-to-Stand Transitions: Effects on Blood Pressure and Glucose Regulation in Postmenopausal Women

By MedXY|Oct 6, 2025

A 3-month randomized trial in overweight postmenopausal women found that increasing sit-to-stand transitions significantly reduces diastolic blood pressure, while reducing total sitting time alone does not improve blood pressure or glucoreg

Patritumab Deruxtecan Shows Promising Efficacy in HR+HER2− Advanced Breast Cancer After CDK4/6 Inhibitor Failure: Insights from ICARUS-BREAST01 Phase 2 Trial
Clinical Updatesantibody-drug conjugatespatritumab deruxtecan

Patritumab Deruxtecan Shows Promising Efficacy in HR+HER2− Advanced Breast Cancer After CDK4/6 Inhibitor Failure: Insights from ICARUS-BREAST01 Phase 2 Trial

By MedXY|Oct 6, 2025

The ICARUS-BREAST01 phase 2 trial demonstrated patritumab deruxtecan’s efficacy and manageable safety in HR+HER2− metastatic breast cancer post-CDK4/6 inhibitors, highlighting key biomarkers linked to response and resistance.

Estradiol Hormone Therapy Route Influences Memory Types in Postmenopausal Women
Clinical Updatescognitive performanceestradiol

Estradiol Hormone Therapy Route Influences Memory Types in Postmenopausal Women

By MedXY|Oct 6, 2025

Estradiol-based hormone therapy’s impact on memory varies by administration route—with transdermal delivery linked to better episodic memory and oral delivery to improved prospective memory. Earlier menopause onset correlates with poo

Everolimus Plus Carboplatin: A Promising Combination for Advanced Triple-Negative Breast Cancer
Clinical UpdatesCarboplatinEverolimus

Everolimus Plus Carboplatin: A Promising Combination for Advanced Triple-Negative Breast Cancer

By MedXY|Oct 6, 2025

A phase 2 study shows adding everolimus to carboplatin significantly improves progression-free survival in advanced TNBC with manageable safety profile, indicating a potential new treatment avenue.

Age-Dependent Survival Outcomes in Early-Stage Endometrial Cancer: Fertility-Preserving Hormonal Therapy Versus Hysterectomy
newsEndometrial Cancerfertility preservation

Age-Dependent Survival Outcomes in Early-Stage Endometrial Cancer: Fertility-Preserving Hormonal Therapy Versus Hysterectomy

By MedXY|Oct 5, 2025

Fertility-preserving hormonal therapy for early-stage endometrial cancer shows comparable 5-year survival to hysterectomy in women under 40, but a significantly higher mortality risk in those aged 40-49 years, highlighting age as a critical

Fertility-Preserving Hormonal Therapy vs Hysterectomy in Early-Stage Endometrial Cancer: Survival Outcomes and Clinical Implications
newsEndometrial Cancerfertility preservation

Fertility-Preserving Hormonal Therapy vs Hysterectomy in Early-Stage Endometrial Cancer: Survival Outcomes and Clinical Implications

By MedXY|Oct 5, 2025

This analysis compares survival in young women with early-stage endometrial cancer treated with fertility-preserving hormonal therapy versus hysterectomy, highlighting survival equivalence in women under 40 years and increased mortality ris

Impact of Maternal Trace Element Levels on Neonatal Growth Among Diabetic and Non-Diabetic Pregnancies
Diabetes & EndocrinologydiabetesPregnancy

Impact of Maternal Trace Element Levels on Neonatal Growth Among Diabetic and Non-Diabetic Pregnancies

By MedXY|Oct 5, 2025

A case–control study reveals that elevated copper levels in diabetic pregnant women negatively affect newborn weight and head circumference, while chromium correlates positively with birth length. Smoking exposure adversely impacts infants’

Prev
18 / 24
1…1617181920…24
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles